Plato Investment Management Ltd Acquires 637 Shares of The Cigna Group (NYSE:CI)

Plato Investment Management Ltd lifted its holdings in shares of The Cigna Group (NYSE:CI) by 4.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,727 shares of the health services provider’s stock after buying an additional 637 shares during the quarter. Plato Investment Management Ltd’s holdings in The Cigna Group were worth $5,097,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of CI. Avantax Advisory Services Inc. raised its position in shares of The Cigna Group by 8.5% during the 1st quarter. Avantax Advisory Services Inc. now owns 3,612 shares of the health services provider’s stock valued at $1,312,000 after acquiring an additional 284 shares during the last quarter. TD Asset Management Inc increased its holdings in The Cigna Group by 13.8% in the first quarter. TD Asset Management Inc now owns 246,601 shares of the health services provider’s stock valued at $89,563,000 after purchasing an additional 29,838 shares during the last quarter. Lord Abbett & CO. LLC lifted its stake in The Cigna Group by 43.9% in the first quarter. Lord Abbett & CO. LLC now owns 3,969 shares of the health services provider’s stock valued at $1,441,000 after buying an additional 1,211 shares during the period. Banco BTG Pactual S.A. boosted its holdings in The Cigna Group by 295.8% during the first quarter. Banco BTG Pactual S.A. now owns 4,908 shares of the health services provider’s stock worth $1,783,000 after buying an additional 3,668 shares during the last quarter. Finally, GM Advisory Group LLC grew its position in shares of The Cigna Group by 14.2% during the 1st quarter. GM Advisory Group LLC now owns 10,668 shares of the health services provider’s stock worth $3,875,000 after buying an additional 1,328 shares during the period. 86.99% of the stock is owned by institutional investors.

The Cigna Group Price Performance

NYSE:CI opened at $331.75 on Thursday. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.71. The firm has a fifty day simple moving average of $340.84 and a 200 day simple moving average of $340.08. The Cigna Group has a 1-year low of $253.95 and a 1-year high of $370.83. The stock has a market capitalization of $92.28 billion, a PE ratio of 31.30, a P/E/G ratio of 1.02 and a beta of 0.51.

The Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $7.51 EPS for the quarter, beating analysts’ consensus estimates of $7.22 by $0.29. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The company had revenue of $63.70 billion during the quarter, compared to the consensus estimate of $59.58 billion. During the same quarter last year, the firm posted $6.77 EPS. The company’s quarterly revenue was up 29.8% on a year-over-year basis. On average, research analysts expect that The Cigna Group will post 28.5 EPS for the current fiscal year.

The Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 19th. Shareholders of record on Wednesday, December 4th will be issued a dividend of $1.40 per share. This represents a $5.60 annualized dividend and a yield of 1.69%. The ex-dividend date is Wednesday, December 4th. The Cigna Group’s dividend payout ratio is 52.83%.

Analysts Set New Price Targets

A number of brokerages recently issued reports on CI. StockNews.com cut shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Deutsche Bank Aktiengesellschaft cut their price objective on The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a report on Monday, November 4th. Jefferies Financial Group raised their target price on shares of The Cigna Group from $402.00 to $422.00 and gave the stock a “buy” rating in a report on Tuesday, September 17th. Barclays increased their price objective on shares of The Cigna Group from $405.00 to $420.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $400.00 price objective on shares of The Cigna Group in a research report on Wednesday, October 23rd. One analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $394.64.

Insiders Place Their Bets

In other news, Director William J. Delaney III sold 2,691 shares of the firm’s stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $342.68, for a total transaction of $922,151.88. Following the completion of the sale, the director now owns 17,539 shares in the company, valued at approximately $6,010,264.52. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 0.60% of the company’s stock.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.